Aardvark Therapeutics Inc (AARD)

R&D Expense Growth

-36.89%

Quarterly · Period ending:

AARD logo

AARD R&D Expense Growth

Latest reported-36.89%
AARD Quarterly R&D Growth (QoQ) (0.00% → -36.89%)
High-resolution chart · PNG

AARD r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aardvark Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-36.8926%
15.8612%
4.0911%
4.5036%
69.5035%
-3.808%
98.3272%
0.8935%
233.8028%
-21.4704%
59.4398%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.